We expect significant earnings growth at Pro Medicus
In very simple terms, PACS refers to the collection, storage, and viewing of scans (eg. CT, MRI) by radiologists. The Visage product is unique in that its pixel streaming technology allows scans to be read almost anywhere, at any time. The technology also reduces file storage and bandwidth requirements when compared to competing products. Visage's accessibility and image load speed are often crucial for time dependent cases.
The past twelve months have seen Pro Medicus convert a large number of opportunities from their prospective PACS pipeline to minimum contracted volumes (on a pay per view basis, with some scope for upside). Pleasingly these wins have come across many different sub segments of the US radiology market, validating the company's belief that the product has a wide range of uses.
To date, the earnings impact has been delayed, however as previously announced contracts ramp up we expect significant earnings growth into FY16 and FY17. Recent high profile wins have also driven increased awareness of the Pro Medicus offer, further boosting the sales pipeline. Successful conversion of these opportunities would offer meaningful earnings upside over the medium term. http://f.datasrvr.com/fr1/115/22209/Perpetual_Pure_Microcap_Flyer_June15.pdf
1 stock mentioned
The Perpetual Equity Investment Company Limited is an ASX listed investment company offering investors access to a portfolio of predominantly high quality Australian and global listed securities, selected by Perpetual Investment Management Limited.